Morningside Venture Capital, a China-focused early-stage VC firm, has raised approximately $1 billion for its latest US dollar-denominated fund. It represents a considerable step up in size from the GP’s previous vehicle, which closed at $660 million in 2015.
Morningside’s last two funds comprised three tranches: a core venture fund, a growth vehicle for later-stage investments, and a co-investment pool. The firm has not specified whether the new offering...
Motilal Oswal Private Equity (MOPE) and healthcare-focused GP Invascent Capital have invested in Indian pharmaceutical developer Symbiotec Pharmalab, providing an exit for Actis Capital.
The transformation of Manuka Health from loosely run family affair into professional segment leader helped organize a cottage industry into big business
A selection of the key fundraising, investment and exit events - presented in chronological order - from the past 12 months
Fuyoukache, a Chinese online truck logistics platform, has raised $170 million in a Series D round led by a Bank of China investment unit and Matrix Partners China. Prospect Avenue Capital also participated.